Drug Target Review2025-09-04T09:00:18
Northwestern University researchers have created DNA-coated nanoparticles that deliver CRISPR into cells three times more effectively while reducing toxicity. The advance could overcome one of the biggest barriers to gene-editing therapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-06T07:26:00Z
Author Dr Tina Rogers
2026-11-05T10:04:00Z
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2026-09-17T07:00:00
Contributor Dr Roland Bürli, Dr Francesca Capotosti and Dr Antonella Pirone, Drug Target Review
2025-05-28T14:00:00
Sponsored by Eurofins DiscoverX
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
2026-10-21T14:02:00
Contributor Jim Corbett, Drug Target Review
Site powered by Webvision Cloud